Esgp inhibitors are a class of chemical compounds designed to target and inhibit the activity of the Esgp protein, which is potentially involved in cellular processes such as gene regulation, protein-protein interactions, or signaling pathways. The exact function of Esgp, or epithelial-stromal growth protein, may be linked to cellular growth regulation, tissue development, or interactions between epithelial and stromal cells, depending on its biological context. By inhibiting Esgp, researchers can explore the specific role this protein plays in modulating intercellular communication and tissue organization, helping to unravel its contributions to cellular dynamics and developmental processes.
The mechanism of action for Esgp inhibitors typically involves binding to key functional domains of the protein that are critical for its activity or interaction with other cellular components. Structurally, Esgp inhibitors may be designed to mimic the natural ligands or substrates of the protein, allowing them to competitively block its functional sites, or they may act by altering the protein's conformation through allosteric inhibition. These inhibitors serve as important tools for investigating how Esgp regulates various cellular pathways, such as those controlling tissue growth, structural organization, or the response to environmental signals. The study of Esgp inhibitors is valuable for understanding the protein's role in maintaining the balance between different cell types within a tissue and how it influences broader processes like tissue architecture and cellular signaling. By inhibiting Esgp, researchers can better understand how this protein contributes to essential biological processes and how its regulation impacts cellular behavior and communication.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $80.00 $175.00 | 28 | |
A PPARδ agonist that can alter the transcriptional programs of muscle cells, possibly affecting pathways that MYMX is involved in. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that can affect chromatin remodeling and thus potentially influence gene expression related to muscle cell fusion. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
An inhibitor of the TGF-β receptor which can modulate myogenic differentiation; this might impact MYMX function indirectly as TGF-β signaling is involved in muscle formation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can affect the AKT signaling pathway, which is important for muscle growth and development, and thus may impact MYMX activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can affect muscle cell growth and differentiation, potentially influencing the environment in which MYMX operates. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor that can affect cytoskeletal dynamics, which could influence membrane fusion processes involving MYMX. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An inhibitor of MEK, which is part of the MAPK/ERK pathway; this can modulate myoblast proliferation and differentiation that could indirectly affect MYMX. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
A γ-secretase inhibitor that can influence Notch signaling, potentially altering the differentiation pathways of muscle cells involving MYMX. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $210.00 $320.00 $1250.00 | 1 | |
An inhibitor of Wnt production, which can affect Wnt signaling involved in muscle development and potentially influence MYMX activity. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
An inhibitor of Wnt processing and secretion that can disrupt Wnt signaling, potentially impacting pathways related to MYMX. |